Delivery Order SPE2DR25D1021-SPE2DR26FNL2M
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count) valued at $1,868.16. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, will be performed at the contractor's Conshohocken, Pennsylvania location. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of dextroamphetamine-amphetamine 10 mg capsules (100-count) with a ceiling value of $1,095.15. This competitively awarded, firm fixed-price delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order carries an ultimate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100 count) valued at $1,122.42. This competitively awarded, firm fixed-price delivery order is expected to be completed by October 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract does not utilize a set-aside designation and represents a child delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100 count) valued at $1,603.56. This firm fixed-price delivery order is scheduled for completion by September 22, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was made through competitive procedures with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count units) with a ceiling value of $2,139.28. This is a firm fixed-price delivery order with an ultimate completion date of September 2, 2025. The award utilized no set-aside designation and was competitively awarded through an open procurement process. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $1,291.32 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100 count) on August 12, 2025, with an ultimate completion date of August 13, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The pharmaceutical supply will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,244.32 to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count units). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 17, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was used in this competitive award. This delivery order is...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count units) with a contract value of $1,150.92. The award was made on a firm fixed-price basis with no set-aside designation, indicating competitive selection. The place of performance is listed as AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,020.12 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100 count) on May 30, 2025, with an ultimate completion date of June 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The pharmaceutical products will be delivered to the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100-count units) with a ceiling value of $1,643.89. This firm fixed-price delivery order, with an ultimate completion date of September 16, 2025, represents a direct procurement from the prime contractor's corporate office located in Conshohocken, Pennsylvania. The award utilized no set-aside designation and was...
- SPE2DR25D1021Indefinite Delivery Contract
- SPE2DR25D1021-SPE2DR26FNL2MDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count containers) with a ceiling value of $4,218.80. This is a firm fixed-price delivery order with an ultimate completion date of October 23, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion prime vendor agreement running through December 2026 that authorizes the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems, and consistently demonstrates its capability to fulfill federal requirements through competitive procurement across numerous therapeutic domains and product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 10/22/25 |